St. Jude Medical Announces Third Quarter Dividend
August 04 2015 - 5:35PM
Business Wire
Board of Directors declare third quarter dividend of $0.29 per
share
St. Jude Medical, Inc. (NYSE:STJ), a global medical device
company, today announced that its Board of Directors declared a
third quarter dividend of $0.29 per common share of the Company’s
stock. This dividend amount is equal to the dividend paid during
the first and second quarters of 2015 and brings the total dividend
declared for the year to $0.87 per share. The dividend is payable
October 30, 2015, to shareholders of record at the close of
business on September 30, 2015.
About St. Jude MedicalSt. Jude Medical is a global
medical device manufacturer dedicated to transforming the treatment
of some of the world’s most expensive epidemic diseases. The
company does this by developing cost-effective medical technologies
that save and improve lives of patients around the world.
Headquartered in St. Paul, Minn., St. Jude Medical has four major
clinical focus areas that include cardiac rhythm management, atrial
fibrillation, cardiovascular and neuromodulation. For more
information, please visit sjm.com or follow us on Twitter
@SJM_Media.
Forward-Looking StatementsThis news release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 that involve risks and
uncertainties. Such forward-looking statements include the
expectations, plans and prospects for the Company, including
potential clinical successes, anticipated regulatory approvals and
future product launches, and projected revenues, margins, earnings
and market shares. The statements made by the Company are based
upon management’s current expectations and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include market conditions and other
factors beyond the Company’s control and the risk factors and other
cautionary statements described in the Company’s filings with the
SEC, including those described in the Risk Factors and Cautionary
Statements sections of the Company’s Annual Report on Form 10-K for
the fiscal year ended January 3, 2015 and Quarterly Report on Form
10-Q for the fiscal quarter ended April 4, 2015. The Company does
not intend to update these statements and undertakes no duty to any
person to provide any such update under any circumstance.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150804007009/en/
St. Jude Medical, Inc.J.C. Weigelt, 651-756-4347Investor
Relationsjweigelt@sjm.comorKate Stoltenberg, 651-756-3388Media
Relationskstoltenberg@sjm.com
SJM (NYSE:STJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Apr 2023 to Apr 2024